Achievements
-
.18,000health-care workers
across 2,082 health-care facilities trained to administer injectable artesunate for severe malaria
-
.Single-dosetafenoquine
for relapse prevention of P. vivax malaria approved by the US FDA
-
.350million
treatments of child-friendly Coartem® Dispersible distributed to more than 50 countries since 2009
Defeating malaria together
Featured resources
-
Why we must prioritize malaria treatment for children
Jan 2019 -
Evaluation of the effects on the QT interval of 4 artemisinin-based combination therapies for the treatment of uncomplicated malaria by use of a correction-free and heart rate-free method
Jan 2019 -
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation
Jan 2019
